190 related articles for article (PubMed ID: 18723002)
1. Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD.
Sciortino MT; Medici MA; Marino-Merlo F; Zaccaria D; Giuffrè-Cuculletto M; Venuti A; Grelli S; Bramanti P; Mastino A
Biochem Pharmacol; 2008 Dec; 76(11):1522-32. PubMed ID: 18723002
[TBL] [Abstract][Full Text] [Related]
2. Involvement of HVEM receptor in activation of nuclear factor kappaB by herpes simplex virus 1 glycoprotein D.
Sciortino MT; Medici MA; Marino-Merlo F; Zaccaria D; Giuffrè-Cuculletto M; Venuti A; Grelli S; Mastino A
Cell Microbiol; 2008 Nov; 10(11):2297-311. PubMed ID: 18671825
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathway used by HSV-1 to induce NF-kappaB activation: possible role of herpes virus entry receptor A.
Teresa Sciortino M; Medici MA; Marino-Merlo F; Zaccaria D; Giuffrè M; Venuti A; Grelli S; Mastino A
Ann N Y Acad Sci; 2007 Jan; 1096():89-96. PubMed ID: 17405920
[TBL] [Abstract][Full Text] [Related]
4. Prevention of the interaction between HVEM, herpes virus entry mediator, and gD, HSV envelope protein, by a Keggin polyoxotungstate, PM-19.
Dan K; Yamase T
Biomed Pharmacother; 2006 May; 60(4):169-73. PubMed ID: 16675194
[TBL] [Abstract][Full Text] [Related]
5. Effects of linker-insertion mutations in herpes simplex virus 1 gD on glycoprotein-induced fusion with cells expressing HVEM or nectin-1.
Jogger CR; Montgomery RI; Spear PG
Virology; 2004 Jan; 318(1):318-26. PubMed ID: 14972557
[TBL] [Abstract][Full Text] [Related]
6. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
Roller DG; Dollery SJ; Doyle JL; Nicola AV
Virology; 2008 Dec; 382(2):207-16. PubMed ID: 18950828
[TBL] [Abstract][Full Text] [Related]
7. Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.
Krummenacher C; Baribaud F; Ponce de Leon M; Baribaud I; Whitbeck JC; Xu R; Cohen GH; Eisenberg RJ
Virology; 2004 May; 322(2):286-99. PubMed ID: 15110526
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.
Nicola AV; Ponce de Leon M; Xu R; Hou W; Whitbeck JC; Krummenacher C; Montgomery RI; Spear PG; Eisenberg RJ; Cohen GH
J Virol; 1998 May; 72(5):3595-601. PubMed ID: 9557640
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus entry mediator associates in infected cells in a complex with viral proteins gD and at least gH.
Perez-Romero P; Perez A; Capul A; Montgomery R; Fuller AO
J Virol; 2005 Apr; 79(7):4540-4. PubMed ID: 15767456
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1.
Yoon M; Zago A; Shukla D; Spear PG
J Virol; 2003 Sep; 77(17):9221-31. PubMed ID: 12915538
[TBL] [Abstract][Full Text] [Related]
12. Enhanced resistance to herpes simplex virus type 1 infection in transgenic mice expressing a soluble form of herpesvirus entry mediator.
Ono E; Yoshino S; Amagai K; Taharaguchi S; Kimura C; Morimoto J; Inobe M; Uenishi T; Uede T
Virology; 2004 Mar; 320(2):267-75. PubMed ID: 15016549
[TBL] [Abstract][Full Text] [Related]
13. Restoring Herpesvirus Entry Mediator (HVEM) Immune Function in HVEM
Tormanen K; Wang S; Jaggi U; Ghiasi H
J Virol; 2020 Jul; 94(16):. PubMed ID: 32522859
[TBL] [Abstract][Full Text] [Related]
14. A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumor cell death and chemokine production.
Pasero C; Barbarat B; Just-Landi S; Bernard A; Aurran-Schleinitz T; Rey J; Eldering E; Truneh A; Costello RT; Olive D
Eur J Immunol; 2009 Sep; 39(9):2502-14. PubMed ID: 19701890
[TBL] [Abstract][Full Text] [Related]
15. Protection against heat and staurosporine mediated apoptosis by the HSV-1 US11 protein.
Javouhey E; Gibert B; Arrigo AP; Diaz JJ; Diaz-Latoud C
Virology; 2008 Jun; 376(1):31-41. PubMed ID: 18395766
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition.
Stiles KM; Whitbeck JC; Lou H; Cohen GH; Eisenberg RJ; Krummenacher C
J Virol; 2010 Nov; 84(22):11646-60. PubMed ID: 20826693
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry.
Whitbeck JC; Peng C; Lou H; Xu R; Willis SH; Ponce de Leon M; Peng T; Nicola AV; Montgomery RI; Warner MS; Soulika AM; Spruce LA; Moore WT; Lambris JD; Spear PG; Cohen GH; Eisenberg RJ
J Virol; 1997 Aug; 71(8):6083-93. PubMed ID: 9223502
[TBL] [Abstract][Full Text] [Related]
18. Caspase 3 activation during herpes simplex virus 1 infection.
Kraft RM; Nguyen ML; Yang XH; Thor AD; Blaho JA
Virus Res; 2006 Sep; 120(1-2):163-75. PubMed ID: 16621101
[TBL] [Abstract][Full Text] [Related]
19. Herpesvirus entry mediator on radiation-resistant cell lineages promotes ocular herpes simplex virus 1 pathogenesis in an entry-independent manner.
Edwards RG; Kopp SJ; Karaba AH; Wilcox DR; Longnecker R
mBio; 2015 Oct; 6(5):e01532-15. PubMed ID: 26489863
[TBL] [Abstract][Full Text] [Related]
20. Spinoculation of heparan sulfate deficient cells enhances HSV-1 entry, but does not abolish the need for essential glycoproteins in viral fusion.
Scanlan PM; Tiwari V; Bommireddy S; Shukla D
J Virol Methods; 2005 Sep; 128(1-2):104-12. PubMed ID: 15908019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
